Benzinga

77995.022.8334%

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Benzinga

Premium Services
Benzinga Edge
Benzinga Pro
Benzinga Research
Benzinga APIs
Financial News
Financial News
Large Cap Stocks
Small-Cap Stocks
Insider Trades
Earnings
Technology
AI News
Personal Finance
ETF News
Crypto News
Dividend News
Latest Rumors
Latest Offerings News
Investment Ideas
Investment Ideas
Stock of the Day
Stock Whisper Index
Analyst Ratings
Analyst Color
Financial Advisors
Government Trades
Trading Ideas
Stock Screener
Markets
Markets
Premarket Movers
After Hours
Options
ETFs
Commodities
Prediction Markets
Private Markets
Bonds
Futures
Forex
Top Stocks
Top Stocks
Apple (AAPL)
Tesla (TSLA)
Amazon (AMZN)
Nvidia (NVDA)
Alphabet (GOOGL)
Meta Platforms (META)
Microsoft (MSFT)
StreetTracks Gold Shares (GLD)
IBIT Bitcoin Trust (IBIT)
Top Value Stocks
Top Momentum Stocks
Top Growth Stocks
Top Quality Stocks
Learn
Learn
Investing Guides
Personal Finance
Mortgages
Best Credit Cards
Best Dividend Stocks
Best Swing Trade Stocks

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Events Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Options Profit Calculator

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Covered Call Calculator

Cash-Secured Put Calculator

Long Call Calculator

Long Put Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

77995.022.8334%

Invesco Biotechnology & Genome ETF Stock News

PBEARCA

Trade with Public

Trade with Public

$96.56

-1.98-2.01%

Last update: Aug 28, 1:03 PM

OverviewNewsHoldings Short Interest

Latest Invesco Biotechnology & Genome ETF News | ARCA:PBE | Benzinga

Get the latest news on Invesco Biotechnology & Genome ETF stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Invesco Biotechnology & Genome ETF performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Saturday, September 27, 2025

Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk
Chandrima Sanyal

Thursday, April 13, 2023

Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
Vandana Singh
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
Vandana Singh

Wednesday, April 12, 2023

New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
Vandana Singh

Tuesday, April 11, 2023

Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
Vandana Singh

Thursday, April 06, 2023

FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
Vandana Singh

Thursday, March 16, 2023

US Judge Weighs Nationwide Ban On Abortion Pills
Vandana Singh

Wednesday, March 01, 2023

FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
Vandana Singh

Monday, June 07, 2021

5 Top ETFs With Exposure To Biogen
Chris Katje

Monday, December 14, 2020

3 ETFs For AstraZeneca's $39B Alexion Pharmaceuticals Takeover
ETF Professor

Friday, September 25, 2020

3 Health Care ETFs Where Components Are Enduring Downgrades
ETF Professor

Tuesday, November 14, 2017

Biotech ETFs: What Lies Ahead?
Benzinga

Friday, October 06, 2017

Heaps Of Healthy Health Care ETFs
Benzinga

Thursday, October 13, 2016

Exclusive: SunTrust Managing Director Discusses Bluebird Bio, A Leader In Gene Therapy
Benzinga

Sunday, February 16, 2014

Biotech And Natural Gas ETFs On A Roll
Benzinga

Thursday, September 05, 2013

Biotech Breakout Highlights Flawed ETF Thinking
Benzinga

Tuesday, June 18, 2013

Interesting Similarities Among 2013's Top-Performing ETFs
Benzinga

Thursday, April 11, 2013

Under The Hood: An Unheralded Biotech ETF
Benzinga

Monday, January 07, 2013

4 Health Care ETFs Your Broker Forgot to Mention
Benzinga

Monday, July 16, 2012

3 Unheralded ETFs Up More Than 10% in the Past 90 Days (PBE, TAGS)
Benzinga

Wednesday, June 27, 2012

Arena Approval Boosts Biotech ETFs (ARNA, IBB, XBI)
Benzinga

Monday, May 21, 2012

The Definitive Biotech ETF Guide (IBB, XBI, FBT)
Benzinga

Thursday, February 23, 2012

Viva Vivus, But Not In ETFs (VVUS, IBB, PJP)
Benzinga

Wednesday, July 20, 2011

Five Health Care ETFs Your Broker Forget To Mention
Benzinga

Wednesday, December 22, 2010

A Biotech ETF for Any Risk Level
Benzinga

Monday, December 06, 2010

ETFs For Biotech M&A Mania
Benzinga

Tuesday, March 09, 2010

Five Biotech ETFs, Which One Is Worth A Look?
Benzinga

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2026 Benzinga | All Rights Reserved